Get the Stockscreener App
1.97
7.07%
0.13
Seastar Medical Holding Corp Stock (ICU) Latest News
Quarterly Metrics: Quick and Current Ratios for SeaStar Medical Holding Corp (ICU) - The Dwinnex
How does SeaStar Medical Holding Corp (ICU) change from a tortoise to a hare? - SETE News
SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market - GlobeNewswire
SeaStar Medical announces $6M registered direct offering priced ATM - MSN
Investing in SeaStar Medical Holding Corp (ICU): What You Must Know - Knox Daily
Investing in Wimi Hologram Cloud Inc ADR (WIMI) Is Getting More Attractive - Knox Daily
SeaStar Medical Secures $6M Through Equity Agreements - TipRanks
Strategic $6M Capital Raise: SeaStar Medical Secures Institutional Backing with Warrant Sweetener - StockTitan
ICU’s earnings forecast for the current quarter - US Post News
ICU Stock: Exploring SeaStar Medical Holding Corp’s Growth - The InvestChronicle
SeaStar Medical receives Nasdaq public reprimand - MSN
SeaStar Medical Holding Co. (NASDAQ:ICUCW) Sees Significant Growth in Short Interest - Defense World
SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market - GlobeNewswire
SeaStar Medical prices 3.53M shares at $1.70 in registered direct offering - TipRanks
SeaStar Medical secures $6 million in direct offering - MSN
SeaStar Medical Raises Fresh Capital: $6M Strategic Investment Fuels Growth Plans - StockTitan
ICU STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE - GlobeNewswire
SeaStar Medical Expands QUELIMMUNE Treatment to Fifth Major Hospital for Critical Pediatric Care - StockTitan
ICU News Today | Why did SeaStar Medical stock go up today? - MarketBeat
SeaStar Medical (NASDAQ:ICU) Stock Price Down 5.7% – Should You Sell? - Defense World
SeaStar Shares Static Ahead of Drug Trials - Baystreet.ca
SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial - GlobeNewswire
SeaStar Medical says FDA approves feasibility study with SCD-ADULT - Yahoo Finance
SeaStar Medical Gains FDA Approval for Pediatric Device - TipRanks
FDA Approves Feasibility Study with SeaStar Medical’s - GlobeNewswire
SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer - GlobeNewswire
Seastar Medical Begins Shipping Quelimmune to A Fourth Hospital Customer - Marketscreener.com
AtriCure (NASDAQ:ATRC) versus SeaStar Medical (NASDAQ:ICU) Critical Contrast - Defense World
Financial Review: Globus Medical (NYSE:GMED) vs. SeaStar Medical (NASDAQ:ICU) - Defense World
ICUSeaStar Medical Holding Corporation Latest Stock News & Market Updates - StockTitan
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial - GlobeNewswire
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial - GlobeNewswire Inc.
Analyzing SeaStar Medical (NASDAQ:ICU) & Aethlon Medical (NASDAQ:AEMD) - Defense World
SEASTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
ICU stock hits 52-week low at $1.82 amid market challenges - Investing.com
Medical Device Co. Brass Hid SPAC's True Value, Suit Says - Law360
SeaStar Medical Projects Multibillion-Dollar Market - GlobeNewswire
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024 - GlobeNewswire
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial - GlobeNewswire
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune - Investing.com Nigeria
SeaStar Medical (NASDAQ:ICU) Trading Down 1.6% – What’s Next? - Defense World
SeaStar Medical reduces authorized shares By Investing.com - Investing.com Canada
SeaStar Medical reduces authorized shares - Investing.com
SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024 - GlobeNewswire
SeaStar Medical to Present at NobleCon20 Conference on Hyperinflammation Solutions | ICU Stock News - StockTitan
Leading Independent Proxy Advisory Firms ISS and Glass - GlobeNewswire
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares - Quantisnow
SeaStar Medical chief medical officer purchases $8,457 in stock By Investing.com - Investing.com Australia
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):